{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:49:37Z","timestamp":1791110977243,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"japan society for the promotion of science","doi-asserted-by":"publisher","award":["JP19K08638"],"award-info":[{"award-number":["JP19K08638"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"japan society for the promotion of science","doi-asserted-by":"publisher","award":["JP21K16153"],"award-info":[{"award-number":["JP21K16153"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Clinical course of pleuroparenchymal fibroelastosis (PPFE) shows considerable variation among patients, but there is no established prognostic prediction model for PPFE.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The prediction model was developed using retrospective data from two cohorts: our single-center cohort and a nationwide multicenter cohort involving 21 institutions. Cox regression analyses were used to identify prognostic factors. The total score was defined as the weighted sum of values for the selected variables. The performance of the prediction models was evaluated by Harrell\u2019s concordance index (C-index). We also examined the usefulness of the gender-age-physiology (GAP) model for predicting the prognosis of PPFE patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We examined 104 patients with PPFE (52 cases from each cohort). In a multivariate Cox analysis, a lower forced vital capacity (FVC [defined as FVC\u2009&lt;\u200965%]; hazard ratio [HR], 2.23), a history of pneumothorax (HR, 3.27), the presence of a lower lobe interstitial lung disease (ILD) (HR, 2.31), and higher serum Krebs von den Lungen-6 (KL-6) levels (&gt;\u2009550 U\/mL, HR, 2.56) were significantly associated with a poor prognosis. The total score was calculated as 1\u2009\u00d7\u2009(FVC, &lt;\u200965%)\u2009+\u20091\u2009\u00d7\u2009(history of pneumothorax)\u2009+\u20091\u2009\u00d7\u2009(presence of lower lobe ILD)\u2009+\u20091\u2009\u00d7\u2009(KL-6, &gt;\u2009550 U\/mL). PPFE patients were divided into three groups based on the prognostic score: stage I (0\u20131 points), stage II (2 points), and stage III (3\u20134 points). The survival rates were significantly different in each stage. The GAP stage was significantly associated with the prognosis of PPFE, but no difference was found between moderate (stage II) and severe (stage III) disease. Our new model for PPFE patients (PPFE Prognosis Score) showed better performance in the prediction of mortality in comparison to the GAP model (C-index of 0.713 vs. 0.649).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our new model for PPFE patients could be useful for predicting their prognosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-021-01810-z","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T11:02:57Z","timestamp":1627642977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["A proposed prognostic prediction score for pleuroparenchymal fibroelastosis"],"prefix":"10.1186","volume":"22","author":[{"given":"Yoshiaki","family":"Kinoshita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takato","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuto","family":"Miyamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisako","family":"Kushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2143-5922","authenticated-orcid":false,"given":"Hiroshi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,30]]},"reference":[{"key":"1810_CR1","first-page":"693","volume":"11","author":"R Amitani","year":"1992","unstructured":"Amitani R, Niimi A, Niimi A, Kuse F. Idiopathic pulmonary upper lobe fibrosis. Kokyu. 1992;11:693\u20139.","journal-title":"Kokyu"},{"key":"1810_CR2","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1378\/chest.126.6.2007","volume":"126","author":"SK Frankel","year":"2004","unstructured":"Frankel SK, Cool CD, Lynch DA, Brown KK. Idiopathic pleuroparenchymal fibroelastosis. Chest [Internet]. 2004;126:2007\u201313.","journal-title":"Chest [Internet]"},{"key":"1810_CR3","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG, et al. An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188:733\u201348.","journal-title":"Am J Respir Crit Care Med"},{"key":"1810_CR4","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/his.13312","volume":"71","author":"Y Kinoshita","year":"2017","unstructured":"Kinoshita Y, Watanabe K, Ishii H, Kushima H, Fujita M, Nabeshima K. Proliferation of elastic fibres in idiopathic pulmonary fibrosis: a whole-slide image analysis and comparison with pleuroparenchymal fibroelastosis. Histopathology. 2017;71:934\u201342.","journal-title":"Histopathology"},{"key":"1810_CR5","unstructured":"Kinoshita Y, Ishii H, Nabeshima K, Watanabe K. The pathogenesis and pathology of idiopathic pleuroparenchymal fibroelastosis. Histol Histopathol. 2021;36:291-303."},{"key":"1810_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2174\/1573398X0904140129125307","volume":"9","author":"K Watanabe","year":"2013","unstructured":"Watanabe K. Pleuroparenchymal fibroelastosis: its clinical characteristics. Curr Respir Med Rev [Internet]. 2013;9:229\u201337.","journal-title":"Curr Respir Med Rev [Internet]"},{"key":"1810_CR7","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1378\/chest.13-2866","volume":"146","author":"T Oda","year":"2014","unstructured":"Oda T, Ogura T, Kitamura H, Hagiwara E, Baba T, Enomoto Y, et al. Distinct characteristics of pleuroparenchymal fibroelastosis with usual interstitial pneumonia compared with idiopathic pulmonary fibrosis. Chest. 2014;146:1248\u201355.","journal-title":"Chest"},{"key":"1810_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.rmed.2018.06.022","volume":"141","author":"H Ishii","year":"2018","unstructured":"Ishii H, Watanabe K, Kushima H, Baba T, Watanabe S, Yamada Y, et al. Pleuroparenchymal fibroelastosis diagnosed by multidisciplinary discussions in Japan. Respir Med. 2018;141:190\u20137.","journal-title":"Respir Med"},{"key":"1810_CR9","doi-asserted-by":"publisher","first-page":"106078","DOI":"10.1016\/j.rmed.2020.106078","volume":"171","author":"Y Suzuki","year":"2020","unstructured":"Suzuki Y, Fujisawa T, Sumikawa H, Tanaka T, Sugimoto C, Kono M, et al. Disease course and prognosis of pleuroparenchymal fibroelastosis compared with idiopathic pulmonary fibrosis. Respir Med [Internet]. 2020;171:106078. https:\/\/doi.org\/10.1016\/j.rmed.2020.106078.","journal-title":"Respir Med [Internet]"},{"key":"1810_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rmed.2017.11.003","volume":"133","author":"Y Enomoto","year":"2017","unstructured":"Enomoto Y, Nakamura Y, Satake Y, Sumikawa H, Johkoh T, Colby TV, et al. Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: a retrospective multicenter study. Respir Med [Internet]. 2017;133:1\u20135.","journal-title":"Respir Med [Internet]"},{"key":"1810_CR11","doi-asserted-by":"publisher","first-page":"1802243","DOI":"10.1183\/13993003.02243-2018","volume":"53","author":"T Fujisawa","year":"2019","unstructured":"Fujisawa T, Mori K, Mikamo M, Ohno T, Kataoka K, Sugimoto C, et al. Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion. Eur Respir J [Internet]. 2019;53:1802243.","journal-title":"Eur Respir J [Internet]"},{"key":"1810_CR12","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1183\/13993003.congress-2019.OA1928","volume":"10","author":"Y Nakamura","year":"2021","unstructured":"Nakamura Y, Mori K, Enomoto Y, Kono M, Sumikawa H, Johkoh T, et al. Prognostic and clinical value of cluster analysis in idiopathic pleuroparenchymal fibroelastosis phenotypes. J Clin Med [Internet]. 2021;10:1498. https:\/\/doi.org\/10.1183\/13993003.congress-2019.OA1928.","journal-title":"J Clin Med [Internet]"},{"key":"1810_CR13","first-page":"846","volume":"10","author":"T Oda","year":"2021","unstructured":"Oda T, Sekine A, Tabata E, Iwasawa T, Takemura T, Ogura T. Comparison of clinical characteristics and outcomes between idiopathic and secondary pleuroparenchymal fibroelastosis. J Clin Med Internet. 2021;10:846.","journal-title":"J Clin Med Internet"},{"key":"1810_CR14","doi-asserted-by":"publisher","first-page":"14074","DOI":"10.1038\/s41598-018-32478-z","volume":"8","author":"Y Suzuki","year":"2018","unstructured":"Suzuki Y, Yoshimura K, Enomoto Y, Yasui H, Hozumi H, Karayama M, et al. Distinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosis. Sci Rep [Internet]. 2018;8:14074.","journal-title":"Sci Rep [Internet]"},{"key":"1810_CR15","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1097\/PAS.0000000000000928","volume":"41","author":"R Khiroya","year":"2017","unstructured":"Khiroya R, Macaluso C, Montero MA, Wells AU, Chua F, Kokosi M, et al. Pleuroparenchymal fibroelastosis: a review of histopathologic features and the relationship between histologic parameters and survival. Am J Surg Pathol [Internet]. 2017;41:1683\u20139.","journal-title":"Am J Surg Pathol [Internet]"},{"key":"1810_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000511965","volume":"100","author":"M Kono","year":"2021","unstructured":"Kono M, Nakamura Y, Enomoto Y, Yasui H, Hozumi H, Karayama M, et al. Pneumothorax in patients with idiopathic pleuroparenchymal fibroelastosis: incidence, clinical features, and risk factors. Respiration. 2021;100:19\u201326.","journal-title":"Respiration"},{"key":"1810_CR17","first-page":"35","volume":"34","author":"H Hayashi","year":"2017","unstructured":"Hayashi H, Nei T, Abe S, Saito Y, Kokuho N, Atsumi K, et al. Body mass index and arterial blood oxygenation as prognostic factors in patients with idiopathic pleuroparenchymal fibroelastosis. Sarcoidosis Vasc Diffus Lung Dis. 2017;34:35\u201340.","journal-title":"Sarcoidosis Vasc Diffus Lung Dis"},{"key":"1810_CR18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1159\/000494061","volume":"97","author":"M Kato","year":"2019","unstructured":"Kato M, Sasaki S, Kurokawa K, Nakamura T, Yamada T, Sasano H, et al. Usual interstitial pneumonia pattern in the lower lung lobes as a prognostic factor in idiopathic pleuroparenchymal fibroelastosis. Respiration [Internet]. 2019;97:319\u201328.","journal-title":"Respiration [Internet]"},{"key":"1810_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.rmed.2019.06.018","volume":"154","author":"M Kono","year":"2019","unstructured":"Kono M, Fujita Y, Takeda K, Miyashita K, Tsutsumi A, Kobayashi T, et al. Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis. Respir Med [Internet]. 2019;154:122\u20136. https:\/\/doi.org\/10.1016\/j.rmed.2019.06.018.","journal-title":"Respir Med [Internet]"},{"key":"1810_CR20","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.resinv.2020.05.009","volume":"58","author":"M Namba","year":"2020","unstructured":"Namba M, Masuda T, Takao S, Terada H, Yamaguchi K, Sakamoto S, et al. Extent of pulmonary fibrosis on high-resolution computed tomography is a prognostic factor in patients with pleuroparenchymal fibroelastosis. Respir Investig [Internet]. 2020;58:465\u201372. https:\/\/doi.org\/10.1016\/j.resinv.2020.05.009.","journal-title":"Respir Investig [Internet]"},{"key":"1810_CR21","doi-asserted-by":"crossref","unstructured":"d\u2019Alessandro M, Bellisai F, Bergantini L, Cameli P, D\u2019Alessandro R, Mazzei MA, et al. Prognostic role of KL-6 in SSc-ILD patients with pleuroparenchymal fibroelastosis. Eur J Clin Invest Internet 2021;51:e13543.","DOI":"10.1111\/eci.13543"},{"key":"1810_CR22","doi-asserted-by":"publisher","first-page":"106077","DOI":"10.1016\/j.rmed.2020.106077","volume":"171","author":"Y Kinoshita","year":"2020","unstructured":"Kinoshita Y, Ikeda T, Kushima H, Fujita M, Nakamura T, Nabeshima K, et al. Serum latent transforming growth factor-\u03b2 binding protein 4 as a novel biomarker for idiopathic pleuroparenchymal fibroelastosis. Respir Med [Internet]. 2020;171:106077.","journal-title":"Respir Med [Internet]"},{"key":"1810_CR23","doi-asserted-by":"publisher","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","volume":"156","author":"B Ley","year":"2012","unstructured":"Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012;156:684\u201395.","journal-title":"Ann Intern Med"},{"key":"1810_CR24","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1378\/chest.13-1474","volume":"145","author":"CJ Ryerson","year":"2014","unstructured":"Ryerson CJ, Vittinghoff E, Ley B, Lee JS, Mooney JJ, Jones KD, et al. Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest. 2014;145:723\u20138.","journal-title":"Chest"},{"key":"1810_CR25","doi-asserted-by":"crossref","unstructured":"Shioya M, Otsuka M, Yamada G, Umeda Y, Ikeda K, Nishikiori H, et al. Poorer prognosis of idiopathic pleuroparenchymal fibroelastosis compared with idiopathic pulmonary fibrosis in advanced stage. Can Respir J [Internet]. 2018. https:\/\/doi.org\/10.1155\/2018\/6043053%0AResearch.","DOI":"10.1155\/2018\/6043053"},{"key":"1810_CR26","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.resinv.2019.02.007","volume":"57","author":"K Watanabe","year":"2019","unstructured":"Watanabe K, Ishii H, Kiyomi F, Terasaki Y, Hebisawa A, Kawabata Y, et al. Criteria for the diagnosis of idiopathic pleuroparenchymal fibroelastosis: a proposal. Respir Investig [Internet]. 2019;57:312\u201320.","journal-title":"Respir Investig [Internet]"},{"key":"1810_CR27","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med [Internet]. 2018;198:e44\u201368. https:\/\/doi.org\/10.1164\/rccm.201807-1255ST.","journal-title":"Am J Respir Crit Care Med [Internet]"},{"key":"1810_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1183\/09059180.00006713","volume":"23","author":"T Harada","year":"2014","unstructured":"Harada T, Yoshida Y, Kitasato Y, Tsuruta N, Wakamatsu K, Hirota T, et al. The thoracic cage becomes flattened in the progression of pleuroparenchymal fibroelastosis. Eur Respir Rev [Internet]. 2014;23:263\u20136. https:\/\/doi.org\/10.1183\/09059180.00006713.","journal-title":"Eur Respir Rev [Internet]"},{"key":"1810_CR29","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.3390\/jcm9113761","volume":"9","author":"T Ikeda","year":"2020","unstructured":"Ikeda T, Kinoshita Y, Ueda Y, Sasaki T, Kushima H, Ishii H. Physiological criteria are useful for the diagnosis of idiopathic pleuroparenchymal fibroelastosis. J Clin Med [Internet]. 2020;9:3761.","journal-title":"J Clin Med [Internet]"},{"key":"1810_CR30","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1001\/jama.298.12.1412","volume":"298","author":"AOO Chan","year":"2007","unstructured":"Chan AOO, Jim MH, Lam KF, Morris JS, Siu DCW, Tong T, et al. Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease. JAMA [Internet]. 2007;298:1412\u20139.","journal-title":"JAMA [Internet]"},{"key":"1810_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4172\/2472-4971.1000111","volume":"01","author":"K Watanabe","year":"2016","unstructured":"Watanabe K. Two different aspects of pleuroparenchymal fibroelastosis: a disease of pulmonary fibrosis, and of the chest wall. J Med Surg Pathol. 2016;01:8\u201311.","journal-title":"J Med Surg Pathol"},{"key":"1810_CR32","doi-asserted-by":"publisher","first-page":"101395","DOI":"10.1016\/j.rmcr.2021.101395","volume":"33","author":"T Ikeda","year":"2021","unstructured":"Ikeda T, Kinoshita Y, Ueda Y, Sasaki T, Kushima H, Ishii H. Severe and progressive platythorax disproportionate to lung fibrosis\u202f: a rare variant of idiopathic pleuroparenchymal fibroelastosis. Respir Med Case Reports [Internet]. 2021;33:101395. https:\/\/doi.org\/10.1016\/j.rmcr.2021.101395.","journal-title":"Respir Med Case Reports [Internet]"},{"key":"1810_CR33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1183\/09031936.00165111","volume":"40","author":"TL Reddy","year":"2012","unstructured":"Reddy TL, Tominaga M, Hansell DM, von der Th\u00fcsen JH, Rassl D, Parfrey H, et al. Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur Respir J. 2012;40:377\u201385.","journal-title":"Eur Respir J"},{"key":"1810_CR34","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/modpathol.2008.56","volume":"21","author":"CD Becker","year":"2008","unstructured":"Becker CD, Gil J, Padilla ML. Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity? Mod Pathol [Internet]. 2008;21:784\u20137.","journal-title":"Mod Pathol [Internet]"},{"key":"1810_CR35","first-page":"87","volume":"37","author":"S Shiota","year":"1999","unstructured":"Shiota S, Shimizu K, Suzuki M, Nakaya Y, Sakamoto K, Iwase A, et al. Seven cases of marked pulmonary fibrosis in the upper lobe. Nihon Kokyuki Gakkai Zasshi. 1999;37:87\u201396.","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"1810_CR36","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1034\/j.1399-3003.1999.14d41.x","volume":"14","author":"E Azoulay","year":"1999","unstructured":"Azoulay E, Paugam B, Heymann MF, Kambouchner M, Haloun A, Valeyre D, et al. Familial extensive idiopathic bilateral pleural fibrosis. Eur Respir J. 1999;14:971\u20133.","journal-title":"Eur Respir J"},{"key":"1810_CR37","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12931-018-0860-6","volume":"19","author":"K Tanizawa","year":"2018","unstructured":"Tanizawa K, Handa T, Kubo T, Chen-Yoshikawa TF, Aoyama A, Motoyama H, et al. Clinical significance of radiological pleuroparenchymal fibroelastosis pattern in interstitial lung disease patients registered for lung transplantation: a retrospective cohort study. Respir Res [Internet]. 2018;19:162. https:\/\/doi.org\/10.1186\/s12931-018-0860-6.","journal-title":"Respir Res [Internet]"},{"key":"1810_CR38","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1164\/ajrccm.165.3.2107134","volume":"165","author":"H Ohnishi","year":"2002","unstructured":"Ohnishi H, Yokoyama A, Kondo K, Hamada H, Abe M, Nishimura K, et al. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med [Internet]. 2002;165:378\u201381.","journal-title":"Am J Respir Crit Care Med [Internet]"},{"key":"1810_CR39","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1164\/ajrccm.158.5.9803115","volume":"158","author":"A Yokoyama","year":"1998","unstructured":"Yokoyama A, Kohno N, Hamada H, Sakatani M, Ueda E, Kondo K, et al. Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis. Am J Respir Crit Care Med [Internet]. 1998;158:1680\u20134.","journal-title":"Am J Respir Crit Care Med [Internet]"},{"key":"1810_CR40","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1440-1843.2006.00834.x","volume":"11","author":"A Yokoyama","year":"2006","unstructured":"Yokoyama A, Kondo K, Nakajima M, Matsushima T, Takahashi T, Nishimura M, et al. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. Respirology [Internet]. 2006;11:164\u20138.","journal-title":"Respirology [Internet]"},{"key":"1810_CR41","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.resinv.2012.06.003","volume":"50","author":"K Watanabe","year":"2012","unstructured":"Watanabe K, Nagata N, Kitasato Y, Wakamatsu K, Nabeshima K, Harada T, et al. Rapid decrease in forced vital capacity in patients with idiopathic pulmonary upper lobe fibrosis. Respir Investig [Internet]. 2012;50:88\u201397.","journal-title":"Respir Investig [Internet]"},{"key":"1810_CR42","doi-asserted-by":"publisher","first-page":"00196","DOI":"10.1183\/23120541.00196-2020","volume":"7","author":"K Sugino","year":"2021","unstructured":"Sugino K, Ono H, Shimizu H, Kurosawa T, Matsumoto K, Ando M, et al. Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia. ERJ Open Res [Internet]. 2021;7:00196\u20132020. https:\/\/doi.org\/10.1183\/23120541.00196-2020.","journal-title":"ERJ Open Res [Internet]"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-021-01810-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-021-01810-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-021-01810-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T12:04:10Z","timestamp":1630065850000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-021-01810-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,30]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1810"],"URL":"https:\/\/doi.org\/10.1186\/s12931-021-01810-z","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,30]]},"assertion":[{"value":"29 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted with approval from the institutional review boards at Fukuoka University Hospital (Approval Numbers: 16-2-23 and C20-09-002).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"215"}}